A 0 1 0 1 O
condom 2 8 2 8 B-contraception_consent
is 9 11 9 11 O
required 12 20 12 20 O
to 21 23 21 23 O
be 24 26 24 26 O
used 27 31 27 31 O
also 32 36 32 36 O
by 37 39 37 39 O
vasectomized 40 52 40 52 B-treatment
men 53 56 53 56 B-gender
in 57 59 57 59 O
order 60 65 60 65 O
to 66 68 66 68 O
prevent 69 76 69 76 O
delivery 77 85 77 85 O
of 86 88 86 88 O
the 89 92 89 92 O
drug 93 97 93 97 O
via 98 101 98 101 O
seminal 102 109 102 109 O
fluid 110 115 110 115 O

Female 0 6 116 122 B-gender
sterilization 7 20 123 136 B-treatment
( 21 22 137 138 O
have 22 26 138 142 O
had 27 30 143 146 O
surgical 31 39 147 155 B-treatment
bilateral 40 49 156 165 I-treatment
oophorectomy 50 62 166 178 I-treatment
with 63 67 179 183 I-treatment
or 68 70 184 186 I-treatment
without 71 78 187 194 I-treatment
hysterectomy 79 91 195 207 I-treatment
) 91 92 207 208 O
or 93 95 209 211 O
tubal 96 101 212 217 B-treatment
ligation 102 110 218 226 I-treatment
at 111 113 227 229 O
least 114 119 230 235 O
six 120 123 236 239 B-lower_bound
weeks 124 129 240 245 I-lower_bound
before 130 136 246 252 O
taking 137 143 253 259 O
study 144 149 260 265 B-treatment
treatment 150 159 266 275 I-treatment

In 0 2 276 278 O
case 3 7 279 283 O
of 8 10 284 286 O
oophorectomy 11 23 287 299 B-treatment
alone 24 29 300 305 O
, 29 30 305 306 O
only 31 35 307 311 O
when 36 40 312 316 O
the 41 44 317 320 O
reproductive 45 57 321 333 O
status 58 64 334 340 O
of 65 67 341 343 O
the 68 71 344 347 O
woman 72 77 348 353 B-gender
has 78 81 354 357 O
been 82 86 358 362 O
confirmed 87 96 363 372 O
by 97 99 373 375 O
follow 100 106 376 382 O
up 107 109 383 385 O
hormone 110 117 386 393 O
level 118 123 394 399 O
assessment 124 134 400 410 O

In 0 2 411 413 O
case 3 7 414 418 O
of 8 10 419 421 O
use 11 14 422 425 O
of 15 17 426 428 O
oral 18 22 429 433 B-contraception_consent
contraception 23 36 434 447 I-contraception_consent
women 37 42 448 453 B-gender
should 43 49 454 460 O
have 50 54 461 465 O
been 55 59 466 470 O
stable 60 66 471 477 O
on 67 69 478 480 O
the 70 73 481 484 O
same 74 78 485 489 O
pill 79 83 490 494 O
for 84 87 495 498 O
a 88 89 499 500 O
minimum 90 97 501 508 O
of 98 100 509 511 O
3 101 102 512 513 B-lower_bound
months 103 109 514 520 I-lower_bound
before 110 116 521 527 O
taking 117 123 528 534 O
study 124 129 535 540 O
treatment 130 139 541 550 B-treatment

Male 0 4 551 555 B-treatment
sterilization 5 18 556 569 I-treatment
( 19 20 570 571 O
at 20 22 571 573 O
least 23 28 574 579 O
6 29 30 580 581 B-lower_bound
months 31 37 582 588 I-lower_bound
prior 38 43 589 594 I-lower_bound
to 44 46 595 597 O
enrolling 47 56 598 607 O
) 56 57 607 608 O
. 57 58 608 609 O
For 59 62 610 613 O
female 63 69 614 620 B-gender
patients 70 78 621 629 I-gender
on 79 81 630 632 O
the 82 85 633 636 O
study 86 91 637 642 O
the 92 95 643 646 O
vasectomized 96 108 647 659 O
male 109 113 660 664 O
partner 114 121 665 672 O
should 122 128 673 679 O
be 129 131 680 682 O
the 132 135 683 686 O
sole 136 140 687 691 O
partner 141 148 692 699 O
for 149 152 700 703 O
that 153 157 704 708 O
patient 158 165 709 716 O

Patient 0 7 717 724 O
has 8 11 725 728 O
been 12 16 729 733 O
permanently 17 28 734 745 O
discontinued 29 41 746 758 O
from 42 46 759 763 O
pasireotide 47 58 764 775 B-treatment
study 59 64 776 781 I-treatment
treatment 65 74 782 791 I-treatment
in 75 77 792 794 O
the 78 81 795 798 O
parent 82 88 799 805 O
study 89 94 806 811 O
due 95 98 812 815 O
to 99 101 816 818 O
unacceptable 102 114 819 831 O
toxicity 115 123 832 840 O
, 123 124 840 841 O
non 125 128 842 845 O
- 128 129 845 846 O
compliance 129 139 846 856 O
to 140 142 857 859 O
study 143 148 860 865 O
procedures 149 159 866 876 O
, 159 160 876 877 O
withdrawal 161 171 878 888 O
of 172 174 889 891 O
consent 175 182 892 899 O
or 183 185 900 902 O
any 186 189 903 906 O
other 190 195 907 912 O
reason 196 202 913 919 O

Patient 0 7 920 927 O
is 8 10 928 930 O
currently 11 20 931 940 O
benefiting 21 31 941 951 O
from 32 36 952 956 O
the 37 40 957 960 O
treatment 41 50 961 970 B-treatment
with 51 55 971 975 O
pasireotide 56 67 976 987 B-treatment
, 67 68 987 988 O
as 69 71 989 991 O
determined 72 82 992 1002 O
by 83 85 1003 1005 O
the 86 89 1006 1009 O
investigator 90 102 1010 1022 O

Patient 0 7 1023 1030 O
is 8 10 1031 1033 O
currently 11 20 1034 1043 O
participating 21 34 1044 1057 O
in 35 37 1058 1060 O
a 38 39 1061 1062 O
Novartis 40 48 1063 1071 O
- 48 49 1071 1072 O
sponsored 49 58 1072 1081 O
study 59 64 1082 1087 O
receiving 65 74 1088 1097 O
pasireotide 75 86 1098 1109 O
( 87 88 1110 1111 O
LAR 88 91 1111 1114 O
and/or 92 98 1115 1121 O
s.c 99 102 1122 1125 O
. 102 103 1125 1126 O
) 103 104 1126 1127 O
on 105 107 1128 1130 O
monotherapy 108 119 1131 1142 B-treatment
or 120 122 1143 1145 O
combination 123 134 1146 1157 B-treatment
therapy 135 142 1158 1165 I-treatment
( 143 144 1166 1167 O
for 144 147 1167 1170 O
Cushing 148 155 1171 1178 B-chronic_disease
's 155 157 1178 1180 I-chronic_disease
Disease 158 165 1181 1188 I-chronic_disease
or 166 168 1189 1191 O
Acromegaly 169 179 1192 1202 B-chronic_disease
) 179 180 1202 1203 O
, 180 181 1203 1204 O
and 182 185 1205 1208 O
has 186 189 1209 1212 O
fulfilled 190 199 1213 1222 O
all 200 203 1223 1226 O
required 204 212 1227 1235 O
assessments 213 224 1236 1247 O
in 225 227 1248 1250 O
the 228 231 1251 1254 O
parent 232 238 1255 1261 O
study 239 244 1262 1267 O
and 245 248 1268 1271 O
patients 249 257 1272 1280 O
that 258 262 1281 1285 O
are 263 266 1286 1289 O
benefiting 267 277 1290 1300 O
from 278 282 1301 1305 O
the 283 286 1306 1309 O
study 287 292 1310 1315 O
treatment 293 302 1316 1325 B-treatment
have 303 307 1326 1330 O
no 308 310 1331 1333 O
other 311 316 1334 1339 O
alternatives 317 329 1340 1352 O

Pregnant 0 8 1353 1361 B-pregnancy
or 9 11 1362 1364 O
nursing 12 19 1365 1372 O
( 20 21 1373 1374 O
lactating 21 30 1374 1383 O
) 30 31 1383 1384 O
women 32 37 1385 1390 B-gender
, 37 38 1390 1391 O
where 39 44 1392 1397 O
pregnancy 45 54 1398 1407 B-pregnancy
is 55 57 1408 1410 O
defined 58 65 1411 1418 O
as 66 68 1419 1421 O
the 69 72 1422 1425 O
state 73 78 1426 1431 O
of 79 81 1432 1434 O
a 82 83 1435 1436 O
female 84 90 1437 1443 B-gender
after 91 96 1444 1449 O
conception 97 107 1450 1460 O
and 108 111 1461 1464 O
until 112 117 1465 1470 O
the 118 121 1471 1474 O
termination 122 133 1475 1486 O
of 134 136 1487 1489 O
gestation 137 146 1490 1499 B-clinical_variable
, 146 147 1499 1500 O
confirmed 148 157 1501 1510 O
by 158 160 1511 1513 O
a 161 162 1514 1515 O
positive 163 171 1516 1524 O
hCG 172 175 1525 1528 B-clinical_variable
laboratory 176 186 1529 1539 I-clinical_variable
test 187 191 1540 1544 I-clinical_variable

Sexually 0 8 1545 1553 O
active 9 15 1554 1560 O
males 16 21 1561 1566 B-gender
, 21 22 1566 1567 O
unless 23 29 1568 1574 O
they 30 34 1575 1579 O
use 35 38 1580 1583 O
a 39 40 1584 1585 O
condom 41 47 1586 1592 O
during 48 54 1593 1599 O
intercourse 55 66 1600 1611 O
while 67 72 1612 1617 O
taking 73 79 1618 1624 O
drug 80 84 1625 1629 O
and 85 88 1630 1633 O
for 89 92 1634 1637 O
1 93 94 1638 1639 B-upper_bound
months 95 101 1640 1646 I-upper_bound
after 102 107 1647 1652 I-upper_bound
pasireotide 108 119 1653 1664 B-treatment
s.c 120 123 1665 1668 O
. 123 124 1668 1669 O
last 125 129 1670 1674 O
dose 130 134 1675 1679 O
and 135 138 1680 1683 O
3 139 140 1684 1685 B-upper_bound
months 141 147 1686 1692 I-upper_bound
after 148 153 1693 1698 I-upper_bound
pasireotide 154 165 1699 1710 O
LAR 166 169 1711 1714 O
last 170 174 1715 1719 O
dose 175 179 1720 1724 O

Use 0 3 1725 1728 B-contraception_consent
of 4 6 1729 1731 I-contraception_consent
oral 7 11 1732 1736 I-contraception_consent
, 11 12 1736 1737 I-contraception_consent
injected 13 21 1738 1746 I-contraception_consent
or 22 24 1747 1749 I-contraception_consent
implanted 25 34 1750 1759 I-contraception_consent
hormonal 35 43 1760 1768 I-contraception_consent
methods 44 51 1769 1776 I-contraception_consent
of 52 54 1777 1779 I-contraception_consent
contraception 55 68 1780 1793 I-contraception_consent
or 69 71 1794 1796 O
placement 72 81 1797 1806 B-contraception_consent
of 82 84 1807 1809 I-contraception_consent
an 85 87 1810 1812 I-contraception_consent
intrauterine 88 100 1813 1825 I-contraception_consent
device 101 107 1826 1832 I-contraception_consent
( 108 109 1833 1834 I-contraception_consent
IUD 109 112 1834 1837 I-contraception_consent
) 112 113 1837 1838 I-contraception_consent
or 114 116 1839 1841 I-contraception_consent
intrauterine 117 129 1842 1854 I-contraception_consent
system 130 136 1855 1861 I-contraception_consent
( 137 138 1862 1863 I-contraception_consent
IUS 138 141 1863 1866 I-contraception_consent
) 141 142 1866 1867 I-contraception_consent
, 142 143 1867 1868 O
or 144 146 1869 1871 O
other 147 152 1872 1877 O
forms 153 158 1878 1883 O
of 159 161 1884 1886 O
hormonal 162 170 1887 1895 O
contraception 171 184 1896 1909 O
that 185 189 1910 1914 O
have 190 194 1915 1919 O
comparable 195 205 1920 1930 O
efficacy 206 214 1931 1939 O
( 215 216 1940 1941 O
failure 216 223 1941 1948 B-clinical_variable
rate 224 228 1949 1953 I-clinical_variable
< 229 230 1954 1955 O
1 230 231 1955 1956 B-upper_bound
% 231 232 1956 1957 I-upper_bound
) 232 233 1957 1958 O
, 233 234 1958 1959 O
for 235 238 1960 1963 O
example 239 246 1964 1971 O
hormone 247 254 1972 1979 B-contraception_consent
vaginal 255 262 1980 1987 I-contraception_consent
ring 263 267 1988 1992 I-contraception_consent
or 268 270 1993 1995 O
transdermal 271 282 1996 2007 B-contraception_consent
hormone 283 290 2008 2015 I-contraception_consent
contraception 291 304 2016 2029 I-contraception_consent

Willingness 0 11 2030 2041 O
and 12 15 2042 2045 O
ability 16 23 2046 2053 O
to 24 26 2054 2056 O
comply 27 33 2057 2063 O
with 34 38 2064 2068 O
scheduled 39 48 2069 2078 O
visits 49 55 2079 2085 O
, 55 56 2085 2086 O
treatment 57 66 2087 2096 B-treatment
plans 67 72 2097 2102 O
and 73 76 2103 2106 O
any 77 80 2107 2110 O
other 81 86 2111 2116 O
study 87 92 2117 2122 O
procedures 93 103 2123 2133 O

Women 0 5 2134 2139 B-gender
are 6 9 2140 2143 O
considered 10 20 2144 2154 O
post 21 25 2155 2159 O
- 25 26 2159 2160 O
menopausal 26 36 2160 2170 O
and 37 40 2171 2174 O
not 41 44 2175 2178 O
of 45 47 2179 2181 O
child 48 53 2182 2187 O
bearing 54 61 2188 2195 O
potential 62 71 2196 2205 O
if 72 74 2206 2208 O
they 75 79 2209 2213 O
have 80 84 2214 2218 O
had 85 88 2219 2222 O
12 89 91 2223 2225 O
months 92 98 2226 2232 O
of 99 101 2233 2235 O
natural 102 109 2236 2243 O
( 110 111 2244 2245 O
spontaneous 111 122 2245 2256 O
) 122 123 2256 2257 O
amenorrhea 124 134 2258 2268 B-chronic_disease
with 135 139 2269 2273 O
an 140 142 2274 2276 O
appropriate 143 154 2277 2288 O
clinical 155 163 2289 2297 O
profile 164 171 2298 2305 O

Women 0 5 2306 2311 B-gender
of 6 8 2312 2314 O
child 9 14 2315 2320 O
- 14 15 2320 2321 O
bearing 15 22 2321 2328 O
potential 23 32 2329 2338 O
, 32 33 2338 2339 O
defined 34 41 2340 2347 O
as 42 44 2348 2350 O
all 45 48 2351 2354 B-gender
women 49 54 2355 2360 I-gender
physiologically 55 70 2361 2376 O
capable 71 78 2377 2384 O
of 79 81 2385 2387 O
becoming 82 90 2388 2396 B-pregnancy
pregnant 91 99 2397 2405 I-pregnancy
, 99 100 2405 2406 O
unless 101 107 2407 2413 O
they 108 112 2414 2418 O
are 113 116 2419 2422 O
using 117 122 2423 2428 B-contraception_consent
highly 123 129 2429 2435 I-contraception_consent
effective 130 139 2436 2445 I-contraception_consent
methods 140 147 2446 2453 I-contraception_consent
of 148 150 2454 2456 I-contraception_consent
contraception 151 164 2457 2470 I-contraception_consent
during 165 171 2471 2477 O
the 172 175 2478 2481 O
study 176 181 2482 2487 O
treatment 182 191 2488 2497 B-treatment
and 192 195 2498 2501 O
for 196 199 2502 2505 O
30 200 202 2506 2508 B-upper_bound
days 203 207 2509 2513 I-upper_bound
after 208 213 2514 2519 I-upper_bound
the 214 217 2520 2523 O
final 218 223 2524 2529 O
dose 224 228 2530 2534 O
of 229 231 2535 2537 O
pasireotide 232 243 2538 2549 B-treatment
s.c 244 247 2550 2553 I-treatment
. 247 248 2553 2554 I-treatment
and 249 252 2555 2558 O
84 253 255 2559 2561 B-upper_bound
days 256 260 2562 2566 I-upper_bound
after 261 266 2567 2572 I-upper_bound
the 267 270 2573 2576 O
final 271 276 2577 2582 O
dose 277 281 2583 2587 O
of 282 284 2588 2590 O
pasireotide 285 296 2591 2602 B-treatment
LAR 297 300 2603 2606 I-treatment

Written 0 7 2607 2614 O
informed 8 16 2615 2623 O
consent 17 24 2624 2631 O
obtained 25 33 2632 2640 O
prior 34 39 2641 2646 O
to 40 42 2647 2649 O
enrolling 43 52 2650 2659 O
in 53 55 2660 2662 O
roll 56 60 2663 2667 O
- 60 61 2667 2668 O
over 61 65 2668 2672 O
study 66 71 2673 2678 O
and 72 75 2679 2682 O
receiving 76 85 2683 2692 O
study 86 91 2693 2698 B-treatment
medication 92 102 2699 2709 I-treatment

